TY - JOUR
T1 - Emerging approaches in the management of intracranial hemorrhage
T2 - ARISE II consensus recommendations
AU - Bain, Mark
AU - Kellner, Christopher Paul
AU - Hanel, Ricardo A.
AU - Burkhardt, Jan Karl
AU - Fiorella, David
AU - Frosen, Juhana
AU - Jankowitz, Brian
AU - Lopes, Demetrius
AU - Pradilla, Gustavo
AU - Taussky, Philipp
AU - Kashkoush, Ahmed
AU - Wakhloo, Ajay K.
AU - Arthur, Adam S.
AU - Mocco, J.
AU - Liebeskind, David S.
AU - Samaniego, Edgar A.
AU - Toth, Gabor
AU - Strbian, Daniel
AU - Linfante, Italo
AU - Nogueira, Raul
AU - Fisher, Marc
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025
Y1 - 2025
N2 - Despite advances in the fundamental understanding of the pathophysiology of intracranial hemorrhage (ICH), many issues related to ICH management remain understudied with discrepancies in management. Given the high disease severity and prevalence, consensus recommendations are urgently needed to guide further research and management strategies. Thus, a group of clinical experts, industry leaders, and government representatives was assembled to examine emerging approaches in ICH management and their future impact on patient care. The timing of intervention within 24 hours and the role of minimally invasive evacuation, particularly for basal ganglia hemorrhage locations, were identified as key research focuses to guide future trial design. Mobile stroke units and artificial intelligence (AI) are promising technologies that streamline preoperative and triaging workflows and improve time to intervention. Efforts to further develop surgical technologies will be crucial to improve ICH visualization and evacuation. Further research, industry collaboration, and investment are needed to advance treatment frontiers and catalyze ICH research.
AB - Despite advances in the fundamental understanding of the pathophysiology of intracranial hemorrhage (ICH), many issues related to ICH management remain understudied with discrepancies in management. Given the high disease severity and prevalence, consensus recommendations are urgently needed to guide further research and management strategies. Thus, a group of clinical experts, industry leaders, and government representatives was assembled to examine emerging approaches in ICH management and their future impact on patient care. The timing of intervention within 24 hours and the role of minimally invasive evacuation, particularly for basal ganglia hemorrhage locations, were identified as key research focuses to guide future trial design. Mobile stroke units and artificial intelligence (AI) are promising technologies that streamline preoperative and triaging workflows and improve time to intervention. Efforts to further develop surgical technologies will be crucial to improve ICH visualization and evacuation. Further research, industry collaboration, and investment are needed to advance treatment frontiers and catalyze ICH research.
KW - Brain
KW - Hemorrhage
UR - https://www.scopus.com/pages/publications/105022083257
U2 - 10.1136/jnis-2025-023855
DO - 10.1136/jnis-2025-023855
M3 - Review article
C2 - 41219123
AN - SCOPUS:105022083257
SN - 1759-8478
JO - Journal of NeuroInterventional Surgery
JF - Journal of NeuroInterventional Surgery
M1 - jnis-2025-023855
ER -